ICD-10-CM Billable Code

E24.1

Nelson's syndrome

Clinical Classification Guidelines

Medical Intelligence & Overview

Nelson's syndrome is a rare condition that can develop after treatment for Cushing's disease, specifically following the removal of both adrenal glands or the pituitary tumor responsible for excess hormone production. It is characterized by the growth of a tumor in the pituitary gland, which leads to an overproduction of the hormone adrenocorticotropic hormone (ACTH). This increase causes characteristic physical changes and can affect overall health. Recognizing the signs and understanding the condition's underlying causes are crucial for effective management and treatment planning.

Causes & Symptoms

Clinical Causes: Surgical removal of the adrenal glands (bilateral adrenalectomy) for uncontrolled Cushing's disease. Inadequate control of the initial pituitary tumor causing excessive ACTH production. Residual or recurrent tumor in the pituitary gland after treatment. Genetic factors may play a role, although specific genetic links are still under investigation.

Key Symptoms: Rapid or progressive darkening of the skin (hyperpigmentation). Headaches, often persistent or worsening over time. Visual disturbances, such as blurred or double vision. Loss of peripheral vision or other visual field defects. Symptoms associated with increased tumor size, like nausea and hormonal imbalances. In some cases, signs of hormonal excess may include fatigue, weakness, or changes in mood.

Diagnostic & Treatment

Diagnosis Path: Diagnosing Nelson's syndrome involves a combination of clinical evaluation, imaging studies, and laboratory tests. The process generally includes: - Brain MRI scans to visualize tumor growth in the pituitary gland. - Blood tests measuring levels of ACTH, which are typically elevated. - Additional hormonal testing to assess pituitary function. - Reviewing patient history, especially previous treatments for Cushing's disease. These assessments help confirm the presence of tumor growth and hormone imbalances characteristic of Nelson's syndrome.

Treatment Protocols: Management of Nelson's syndrome aims to control tumor growth, reduce hormone overproduction, and alleviate symptoms. Treatment options include: - Surgical removal of the pituitary tumor, often via transsphenoidal surgery. - Radiotherapy to shrink or control tumor growth when surgery is not entirely effective. - Medical therapies, such as medications that suppress ACTH production or block its effects. - Regular monitoring of hormone levels and imaging to detect recurrence or progression. The choice of treatment depends on the tumor’s size, location, patient health, and response to previous therapies. Multidisciplinary care involving endocrinologists, neurosurgeons, and radiologists often provides the best outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E24.1 a billable ICD-10 code?
Yes, E24.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E24.1?
Clinical documentation must specify the nature of Nelson's syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

syndrome